DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,715,793 | +1.2% | 14,977 | -2.1% | 3.85% | +10.3% |
| Q2 2023 | $3,673,200 | -9.3% | 15,305 | -4.8% | 3.49% | -8.1% |
| Q1 2023 | $4,051,543 | -6.1% | 16,075 | -1.1% | 3.80% | -10.3% |
| Q4 2022 | $4,313,605 | +1.8% | 16,252 | -0.9% | 4.24% | -4.2% |
| Q3 2022 | $4,236,000 | -0.1% | 16,402 | -2.0% | 4.42% | +9.9% |
| Q2 2022 | $4,242,000 | -17.4% | 16,735 | -4.4% | 4.02% | +0.5% |
| Q1 2022 | $5,137,000 | -13.9% | 17,514 | -3.4% | 4.00% | -2.1% |
| Q4 2021 | $5,964,000 | +1.9% | 18,126 | -5.7% | 4.09% | -5.9% |
| Q3 2021 | $5,852,000 | +3.3% | 19,223 | -8.9% | 4.35% | +7.7% |
| Q2 2021 | $5,664,000 | +17.1% | 21,107 | -1.8% | 4.04% | +11.6% |
| Q1 2021 | $4,835,000 | -3.4% | 21,483 | -4.7% | 3.62% | -4.3% |
| Q4 2020 | $5,006,000 | -4.2% | 22,537 | -7.1% | 3.78% | -12.9% |
| Q3 2020 | $5,227,000 | +10.2% | 24,272 | -9.5% | 4.34% | +3.6% |
| Q2 2020 | $4,742,000 | +19.3% | 26,809 | -6.6% | 4.19% | +6.1% |
| Q1 2020 | $3,974,000 | -15.0% | 28,712 | -5.7% | 3.95% | +4.7% |
| Q4 2019 | $4,675,000 | +2.7% | 30,462 | -3.4% | 3.77% | -1.3% |
| Q3 2019 | $4,552,000 | -2.2% | 31,522 | -3.2% | 3.82% | +0.3% |
| Q2 2019 | $4,656,000 | +2.8% | 32,578 | -5.0% | 3.81% | +0.9% |
| Q1 2019 | $4,528,000 | +27.4% | 34,290 | -0.5% | 3.78% | +9.9% |
| Q4 2018 | $3,554,000 | -5.2% | 34,465 | -0.0% | 3.44% | +8.6% |
| Q3 2018 | $3,747,000 | +10.4% | 34,480 | +0.3% | 3.17% | +2.2% |
| Q2 2018 | $3,394,000 | +0.1% | 34,390 | -0.7% | 3.10% | +0.9% |
| Q1 2018 | $3,390,000 | +5.5% | 34,625 | +0.0% | 3.07% | +9.7% |
| Q4 2017 | $3,213,000 | +10.8% | 34,610 | +2.3% | 2.80% | +9.6% |
| Q3 2017 | $2,901,000 | +0.8% | 33,825 | -0.8% | 2.55% | +1.6% |
| Q2 2017 | $2,879,000 | -0.9% | 34,110 | +0.4% | 2.51% | -2.9% |
| Q1 2017 | $2,906,000 | +21.0% | 33,990 | +10.2% | 2.59% | +12.9% |
| Q4 2016 | $2,401,000 | +44.7% | 30,835 | +45.7% | 2.30% | +40.8% |
| Q3 2016 | $1,659,000 | +10.6% | 21,165 | +42.6% | 1.63% | +8.2% |
| Q2 2016 | $1,500,000 | +190.1% | 14,845 | +171.9% | 1.51% | +185.2% |
| Q1 2016 | $517,000 | – | 5,460 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |